Results 131 to 140 of about 51,331 (226)

Unexpected resolution of clozapine-induced obsessive-compulsive symptoms with cariprazine augmentation: a case report. [PDF]

BMC Psychiatry
Rammouz I, El Oumary O, Hamri S, Akebour K, Mouhadi K, Doufik J, Boujraf S.   +6 more
europepmc   +1 more source

Subcortical volume alteration and correlation with social function under chlorpromazine versus clozapine treatment in schizophrenia. [PDF]

BMC Psychiatry
Gao J, Jia J, Jiang Q, Yang P, Li J, Zhang X, Zhang X, Tang X.   +7 more
europepmc   +1 more source

Study of the Lipophilicity of Tetracyclic Anticancer Azaphenothiazines. [PDF]

Biomolecules
Jeleń M, Morak-Młodawska B, Dołowy M, Konefał A.   +3 more
europepmc   +1 more source

Intravenous haloperidol or chlorpromazine-which is more effective to improve agitation and communication in agitated delirium at the end of life? [PDF]

Oncologist
Uchida M, Morita T, Akechi T, Kawahara T, Ogawa A, Yoshiuchi K, Yokomichi N, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S, Uchida M, Morita T, Akechi T, Kawahara T, Ogawa A, Yoshiuchi K, Yokomichi N, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S.   +23 more
europepmc   +1 more source

Special feature on antipsychotic discontinuation in schizophrenia. [PDF]

Schizophrenia (Heidelb)
Taylor D.
europepmc   +1 more source

What is Minimally Adequate Treatment of Psychosis and Should Duration of Inadequate Treatment be a Clinical and Research Target? A Perspective and State-of-the-Art Review. [PDF]

Schizophr Bull
Osugo M, Howes OD.
europepmc   +1 more source

Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis. [PDF]

PCN Rep
Nagai Y, Mamiko M, Miyakawa K.
europepmc   +1 more source

COVID-19 Infection Changed P300 Latency in Patients With Psychosis: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Jiang X, Qiu S, Wang W, Xu S, Wang S.
europepmc   +1 more source

A physics-informed neural network framework for quantitative analysis of transcytosis and physical diffusion in an in vitro BBB. [PDF]

J Nanobiotechnology
Wang X, Shen B, Yang W, Wang X, Li C, Wu H.   +5 more
europepmc   +1 more source

Treatment of disruptive mood dysregulation disorder with autism spectrum disorder and attention-deficit/hyperactivity disorder. [PDF]

Ment Health Clin
Mitchell S.
europepmc   +1 more source